SCHEMBL4606363

SCHEMBL4606363

CS(=O)(=O)c1nsc(-c2ccccc2F)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.42
SCD O00767 3/20 0.39
FADS1 O60427 1/20 0.39
RIPK1 Q13546 1/20 0.38
KDM4E B2RXH2 2/20 0.38
SDHB P21912 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GRIA4 P48058 1/20 0.38
PTGS1 P23219 1/20 0.37
MPL P40238 1/20 0.37
MITF O75030 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
STAT3 P40763 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SLC9A1 P19634 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606713 0.84 PTGS2 (0.46) PTGS2SCDKDM4EALDH1A1PTGS1
SCHEMBL4603583 0.79 ADORA3 (0.50) PTGS2KDM4ESDHBALDH1A1LMNA
SCHEMBL4606885 0.73 CHRNA7 (0.48) PTGS2SCDKDM4E
SCHEMBL4603390 0.71 TSHR (0.42) KDM4EALDH1A1MPLLMNA
SCHEMBL8947147 0.70 NPC1 (0.43) KDM4EALDH1A1HPGDHTT
SCHEMBL25231962 0.70 SDHB (0.41) PTGS2SCDKDM4ESDHBALDH1A1
SCHEMBL5831677 0.67 ALOX5AP (0.48) PTGS2KDM4EALDH1A1GRIA4PTGS1
SCHEMBL19805662 0.67 SDHB (0.76) PTGS2KDM4ESDHBALDH1A1MITF
SCHEMBL5593113 0.66 KMT2A (0.58) PTGS2SCDFADS1KDM4ESDHB
SCHEMBL29593862 0.66 ADORA2A (0.38) PTGS2SCDFADS1RIPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 PTGS2 2797/4885SCD 4597/4885FADS1 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.